Citation Impact
Citing Papers
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
The clinical symptoms of Parkinson's disease
2016 Standout
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
2005 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Parkinson disease
2017 Standout
Parkinson's disease
2021 Standout
Antioxidant supplementation attenuates oxidative stress in chronic hepatitis C patients
2012
Correlates of physical activity: why are some people physically active and others not?
2012 Standout
Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease
2004
Mechanism and medical implications of mammalian autophagy
2018 Standout
An inflammatory review of Parkinson’s disease
2002
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Parkinson’s Disease as a Disconnection Syndrome
2010
Molecular pathogenesis of Parkinson disease: insights from genetic studies
2009
Gender effect on non-motor symptoms in Parkinson's disease: are men more at risk?
2016
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Verbal fluency deficits in multiple sclerosis
2005
Epidemiology of Parkinson's disease
2006 Standout
Cognitive impairment in multiple sclerosis
2008 Standout
Levodopa in the treatment of Parkinson’s disease
2009
Spectrum of Mutations in Biopsy-Proven CADASIL
2005
Parkinson's disease
2009 Standout
No association between APOE epsilon 4 allele and multiple sclerosis susceptibility: A meta-analysis from 5472 cases and 4727 controls
2011
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Structural Imaging in Parkinson’s Disease: New Developments
2019
Parkinson's disease
2015 Standout
Pathophysiological distortions in time perception and timed performance
2011 Standout
Hereditary cerebral small vessel diseases: A review
2012
The neuropathology of genetic Parkinson's disease
2012
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Advances in the genetics of Parkinson disease
2013
Role of apolipoprotein E in neurodegenerative diseases
2015
Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions
2008
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Age at onset of Parkinson disease and apolipoprotein E genotypes
2001
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Non-motor features of Parkinson disease
2017 Standout
DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders
2009
p53‐dependent neuronal cell death in a DJ‐1‐deficient zebrafish model of Parkinson's disease
2006
CADASIL mutations impair Notch3 glycosylation by Fringe
2005
Relationship of Apolipoprotein E and Age at Onset to Parkinson Disease Neuropathology
2006
Genetics of ischaemic stroke
2007
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes
2002
Antioxidant intervention attenuates oxidative stress in children and teenagers with Down syndrome
2014
The Pathobiology of Vascular Dementia
2013 Standout
A dopamine D2 receptor gene polymorphism and physical activity in two family studies
2003
Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease
2008
Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
2013
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
2008 StandoutNobel
The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
2014
CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain
2008 StandoutNobel
Parkinson's Disease
2003 Standout
Selective Decline in Information Processing in Subgroups of Multiple Sclerosis: An 8-Year Longitudinal Study
2007
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Models of α-synuclein aggregation in Parkinson’s disease
2014
CADASIL
2009 Standout
2016
APOE-ε2 allele associated with higher prevalence of sporadic Parkinson disease
2004
Dopamine Dysregulation Syndrome
2009
Diagnosis and Treatment of Parkinson Disease
2020 Standout
The neurobiological basis of cognitive impairment in Parkinson's disease
2014
Metabolic control of cell death
2014 Science
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: A Genetic Cause of Cerebral Small Vessel Disease
2010
Oxidative stress, mitochondrial damage and neurodegenerative diseases.
2013 Standout
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
An Updated Definition of Stroke for the 21st Century
2013 Standout
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging
2006
Works of Manuela Caracciolo being referenced
APOE and risk of cognitive impairment in multiple sclerosis
2009
DJ‐1 mutations and parkinsonism‐dementia‐amyotrophic lateral sclerosis complex
2005
Anti-GM1 ganglioside antibodies in Parkinson's disease
2002
The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease
2000
Apolipoprotein E polymorphisms and Parkinson's disease
1999
Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson's disease
2002
Body Weight Influences Pharmacokinetics of Levodopa in Parkinson's Disease
2002
MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP–parkinsonism
2016
A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL
2004
Plasma levels of vitamin E in Parkinson's disease
2001
The long-duration response to l -dopa in the treatment of early PD
2000
Refining initial diagnosis of Parkinson's disease after follow‐up: A 4‐year prospective clinical and magnetic resonance imaging study
2019